Document Type : Letter to Editor

Author

Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

10.48305/arya.2025.43337.3016

Keywords

  1. Tjahjono HA, Barlianto W, Handayani D, Kalim H. Correlation between transforming growth factor-β1 (TGF- β1) with premature atherosclerosis in type 1 diabetes. ARYA Atheroscler. 2024;20(4):7-13. https://doi.org/10.48305/arya.2024.11581.2125
  2. Rochmah N, Triastuti IW, Deakandi WY, Irawan R, Faizi M, Endaryanto A. Decreased serum transforming growth factor-beta levels in Indonesian children with type 1 diabetes. J Med Pharm Chem Res 2024; 6(9):1478-84. https://doi.org/10.48309/ecc.2024.434749.1746
  3. Chen PY, Qin L, Simons M. TGFβ signaling pathways in human health and disease. Front Mol Biosci. 2023 Jun 1;10:1113061. https://doi.org/10.3389/fmolb.2023.1113061
  4. He C, Kim HI, Park J, Guo J, Huang W. The role of immune cells in different stages of atherosclerosis. Int J Med Sci. 2024 Apr 22;21(6):1129-43. https://doi.org/10.7150/ijms.94570
  5. Liuizė Abramavičiūtė A, Mongirdienė A. TGF-β Isoforms and GDF-15 in the Development and Progression of Atherosclerosis. Int J Mol Sci. 2024 Feb 9;25(4):2104. https://doi.org/10.3390/ijms25042104
  6. Chen PY, Qin L, Li G, Wang Z, Dahlman JE, Malagon-Lopez J, et al. Endothelial TGF-β signalling drives vascular inflammation and atherosclerosis. Nat Metab. 2019 Sep;1(9):912-26. https://doi.org/10.1038/s42255-019-0102-3